Federal Government Caught Buying ‘Fresh’ Flesh Of Aborted Babies Who Could Have Survived As Preemies

Estimated Reading Time: 3 minutes

Americans should be outraged their government participates in the wide-scale human trafficking operation that created a market for harvesting the organs of murdered infants.

This article contains disturbing information about human dismemberment.

Last week, legal accountability group Judicial Watch dropped a bombshell: a nearly 600-page report proving the U.S. government has been buying and trafficking “fresh” aborted baby body parts. These body parts, purchased by the U.S. Food and Drug Administration to “humanize” mice and test biologic drugs in scientific experiments, came from babies up to 24-weeks-old gestation, just weeks from being born.

While Americans may be used to hearing pro-lifers beat the warning drum on abortion groups harvesting baby bodies and selling them for research, (who hasn’t heard of the lawsuit against David Daleiden, who exposed Planned Parenthood haggling over baby lungs and livers at dinner parties?) this time, the U.S. government was the one trafficking baby parts.

Recent emails uncovered by Judicial Watch between FDA employees and the California-based Advanced Bioscience Resources (ABR) prove the agency spent tens of thousands of dollars buying aborted babies for unethical scientific experiments between 2012 and 2018. In 2018, the Trump administration terminated the contract, halting government fetal tissue research due to concerns the contracts were unlawful. Judicial Watch’s new FOIA Request adds 575 pages of records to its existing 2019 lawsuit against the agency.

Caught Red-Handed

This is not the first time ABR has been in the spotlight, as the company was under congressional investigation for its long-standing involvement in fetal tissue trafficking. One of the oldest fetal tissue procurement firms, the company makes millions every year by harvesting organs like lungs, livers, eyeballs, and brains from aborted babies and re-selling them at a profit.

Emails between FDA officials and ABR employees reveal disturbing conversations as they collaborate to buy and sell aborted fetuses. Records indicate ABR was paid $12,000 upfront per baby, some survivable out of the womb, between the gestational age of 16-24 weeks. Most purchases are for intact thymuses and livers shipped “Fresh; on wet ice.”

With the callousness of picking a cut of meat from a butcher shop, an FDA doctor requests tissue samples be procured from a baby boy, as they claim “It is strongly preferred to have a male fetus if at all possible … [but] undetermined sex or female is better than no tissue.”

Even more appalling is an ABR employee complaining about the difficulty of identifying the sex of aborted babies. “We only check external genitalia and if it’s not there … we have no way of telling.” The fact techs are unable to identify the sex of aborted babies is no surprise to those familiar with the barbaric nature of abortion procedures, which require clinic staff to piece together mangled remains of babies after their limbs and organs are torn apart.

As if these casual orders weren’t horrific enough, more emails confirm that the FDA bought organs of babies who were aborted well after 20 weeks gestation, after the time a baby usually can survive outside the womb. If nothing else, this confirms the reality of late-term abortions in the United States, which pro-abortion cheerleaders have denied for decades.

When an ABR employee reassured the FDA they were working with doctors who performed late-term abortions, he admitted some tissue was unusable from a procedure that injects a poison called digoxin into the baby, destroying its cells and tissues. Once the chemical has done its work, an intact, dead baby is delivered. This method makes fetal tissue specimens unusable in experiments; with digoxin off the table, the likelihood partial-birth abortions were used is sickeningly high.

These conversations should shock even those who are pro-abortion, most of whom believe in significant term restrictions. Babies at this level of development possess all characteristics necessary for surviving life outside the womb and premature children born as young as 21 weeks go on to lead healthy, thriving lives.

An Atrocity Against Human Dignity

These gruesome excerpts are just a sample of records substantiating the 2019 lawsuit Judicial Watch filed against HHS, which houses the FDA. In March this year, a federal court ordered the agency to release records it withheld about purchasing organs of aborted babies, saying it found “reason to question” the transactions violated federal law.

The court’s decision found that the U.S. government bought second-trimester livers, thymuses, brains, eyes, and lungs for hundreds of dollars apiece from ABR, stating ABR could collect “over $2,000 on a single fetus it purchased … for $60” and “the federal government participated in this potentially illicit trade for years.”

Americans should be outraged their government participates in the wide-scale human trafficking operation that created a market for harvesting the organs of murdered infants. In no humane society could such a violation of the human body and dignity occur, in which babies’ eyes are “harvested immediately upon death,” organs marketed based on sex, and personhood attributed to mice but not children.

Until demanded otherwise, our society is complicit in the unchecked abuse and commodification of preborn children. Moral urgency is incumbent on us to condemn these atrocities sanctioned by the federal government’s lead medical researchers and fight to stop them. We may lose more battles before we win, but we cannot say we never knew.

*****

This article was published on April 15, 2021 and is reproduced with permission from The Federalist.

Print Friendly, PDF & Email